Woodline Partners LP 13D/13G Filings for Travere Therapeutics, Inc. (TVTX)

Woodline Partners LP 13D and 13G filings for Travere Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
1:01 pm
Purchase
2024-09-3013GTravere Therapeutics, Inc.
TVTX
Woodline Partners LP4,340,340
5.700%
4,340,340increase
(New Position)
Filing